Evidence map›Paper›PMID 34152962›Full record

ArticleEmerging infectious diseases2021

Effects of Coronavirus Disease Pandemic on Tuberculosis Notifications, Malawi.

Rebecca Nzawa Soko, Rachael M Burke, Helena R A Feasey, Wakumanya Sibande, Marriott Nliwasa, Marc Y R Henrion, McEwen Khundi, Peter J Dodd, Chu Chang Ku, Gift Kawalazira and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Household Contact Tracing With Intensified Tuberculosis and Human Immunodeficiency Virus Screening in South Africa: A Cluster-Randomized Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in Botswana.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Rebecca Nzawa Soko
Rachael M Burke
Helena R A Feasey
Wakumanya Sibande
Marriott Nliwasa
Marc Y R Henrion
McEwen Khundi
Peter J Dodd
Chu Chang Ku
Gift Kawalazira
Augustine T Choko
Titus H Divala
Elizabeth L Corbett
Peter MacPherson
Malawi-Liverpool-Wellcome Trust Clinical Research Programme · MWLondon School of Hygiene & Tropical Medicine · GBUniversity of Liverpool · GBUniversity of Malawi · MWUniversity of Sheffield · GBLiverpool School of Tropical Medicine · GB

Funding

Medical Research Council MR/P022081/1Wellcome Trust 200901/Z/16/ZWellcome Trust 206575/Z/17/Z
6 · The paper itself

Abstract

The coronavirus disease (COVID-19) pandemic might affect tuberculosis (TB) diagnosis and patient care. We analyzed a citywide electronic TB register in Blantyre, Malawi and interviewed TB officers. Malawi did not have an official COVID-19 lockdown but closed schools and borders on March 23, 2020. In an interrupted time series analysis, we noted an immediate 35.9% reduction in TB notifications in April 2020; notifications recovered to near prepandemic numbers by December 2020. However, 333 fewer cumulative TB notifications were received than anticipated. Women and girls were affected more (30.7% fewer cases) than men and boys (20.9% fewer cases). Fear of COVID-19 infection, temporary facility closures, inadequate personal protective equipment, and COVID-19 stigma because of similar symptoms to TB were mentioned as reasons for fewer people being diagnosed with TB. Public health measures could benefit control of both TB and COVID-19, but only if TB diagnostic services remain accessible and are considered safe to attend.

Indexed as

COVID-19TuberculosisCommunicable Disease ControlFemaleHumansMalawiMalePandemicsSARS-CoV-2bacteriacoronaviruscoronavirus diseaseCOVID-19disease surveillancehealth systemsrespiratory infectionsSARSSARS-CoV-2severe acute respiratory syndrome coronavirus 2tuberculosisviruseszoonoses

Identifiers

PMID34152962
PMCPMC8237899
OpenAlexW3175261527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.